Thursday July 2, 2020

DCC completes acquisition of Kent Pharmaceuticals

DCC has said that it has completed the acquisition of British generic drugs company Kent Pharmaceuticals in a move that it has said will significantly increase the scale of its pharma business.

27th February, 2013

DCC has said that it has completed the acquisition of British generic drugs company Kent Pharmaceuticals in a move that it has said will significantly increase the scale of the company’s pharma business.

The deal is based on an enterprise valuation of €71.2 million, according to information previously released by DCC.

Kent is involved in the development, manufacture, sales, marketing and distribution of generic pharmaceuticals for the British, Irish and international markets. It...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 6 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago